Prediction of nonresponsiveness to medium-dose intravenous immunoglobulin (1 g/kg) treatment: an effective and safe schedule of acute treatment for Kawasaki disease

• Main Authors: Kyung Pil Moon (Author), Beom Joon Kim (Author), Kyu Jin Lee (Author), Jin Hee Oh (Author), Ji Whan Han (Author), Kyung Yil Lee (Author), Soon Ju Lee (Author)
• Format: Book
• Published: Korean Pediatric Society, 2016-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

PurposeMedium-dose (1 g/kg) intravenous immunoglobulin (IVIG) is effective in the majority of patients with Kawasaki disease (KD) but some patients who do not respond to medium-dose IVIG are at high risk for the development of coronary artery lesions (CALs). The purpose of this study was to identify...